REAL-TIME GLOBAL RESEARCH
Keymed (2162.HK) 1H26 Result: Stapokibart FY26 Guidance Raised; Catalyst Rich in 2H26 and 1H27
Research evidence excerpt
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer